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Abstract 
Pneumatosis intestinalis (PI) is the presence of gas within the wall of the gastrointestinal 
tract and represents a tremendous spectrum of conditions and outcomes, ranging from 
benign diseases to abdominal sepsis and death. It is seen with increased frequency in 
patients who are immunocompromised because of steroids, chemotherapy, radiation 
therapy, or AIDS. PI may result from intraluminal bacterial gas entering the bowel wall 
due to increased mucosal permeability caused by defects in bowel wall lymphoid tissue. 
We present a case of PI who was treated conservatively and in whom PI resolved 
completely and we present a literature review of conservative management. It is not 
difficult to make a precise diagnosis of PI and to prevent unnecessary surgical 
intervention, especially when PI presents without clinical evidence of peritonitis. 
Conservative treatment is possible and safe for selected patients. Awareness of these 
rare causes of PI and close observation of selected patients without peritonitis may 
prevent unnecessary invasive surgical explorations. 
 
Introduction 
Pneumatosis intestinalis (PI) is the presence of gas within the wall of the 
gastrointestinal tract [1] and is not a diagnosis but a radiographic finding that results 
from an underlying pathologic process. The significance of PI depends on the nature and 
severity of the underlying condition. Therefore, PI represents a tremendous spectrum of 
conditions and outcomes, ranging from benign diseases to abdominal sepsis and death 
[2]. 
Pneumatosis is found secondary to mucosal disruption presumably due to 
overdistension; it is often linear or cystic in appearance, seen with increased frequency in 
patients who are immunocompromised because of steroids, chemotherapy, radiation  
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therapy, or AIDS. In these cases, pneumatosis may result from intraluminal bacterial gas 
entering the bowel wall due to increased mucosal permeability caused by defects in bowel 
wall lymphoid tissue. Clinical and imaging findings are important in the differentiation of 
this transient pneumatosis from fulminant life-threatening causes in this subset of 
patients. The presence of pneumoperitoneum is the result of a perforation of the 
gastrointestinal tract in over 90% of PI patients [3]. In this condition, the signs and 
symptoms of peritoneal irritation are almost always present and generally the patients 
require prompt surgical intervention. However, on rare occasions, pneumoperitonitis can 
occur without any gastrointestinal leakage [4]. 
Case Report 
A 75-year-old Caucasian lady was diagnosed with stage IIB endometroid adenocarcinoma in 2005. 
She underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic and 
paraaortic lymph node dissection; she refused adjuvant radiotherapy and was subsequently treated with 
4 cycles of a chemotherapeutic regimen consisting of carboplatin and paclitaxel. The patient was unable 
to tolerate the full treatment course since she developed gastrointestinal bleeding following the fourth 
dose, so her chemotherapeutic medications were discontinued. The patient was admitted to hospital in 
March 2006 with increasing breathing difficulties and worsening ascites, at which point the was found 
on imaging to have recurrence and spread of her initial cancer. She had developed multiple peritoneal 
implants and pulmonary metastases, so the decision was made to start her on ribosomal doxorubicin 
(Caelyx), of which she received 3 cycles, the last one in May 2007. She presented one week after her 
third cycle of chemotherapy to the emergency department because she had been vomiting excessively 
for two consecutive days. She had had a moderate amount of abdominal discomfort associated with 
increasing ascites gradually worsening over the week prior to admission. She had not had any flatus for 
2 days prior to her arrival. The patient was admitted for observation, and it was thought that her 
symptoms were likely attributable to her last dose of Caelyx that she had received a few days prior. In 
any respect, the patient was kept fasting in case she had some small bowel obstruction. She underwent a 
CT scan of the pelvis and abdomen which demonstrated a large loculated ascites, causing an obstruction 
to the gastric outlet at the level of the mesenteric vessels with distension of the duodenum and stomach, 
which were representative of extensive pneumatosis (fig. 1). In addition, there was a fairly extensive 
amount of portal air and free air around the stomach which was highly suggestive of small bowel 
perforation. Clinically there were no signs of peritonitis and bowel sounds were absent, and the decision 
was made to treat the patient conservatively since she was not a surgical candidate given the extent of 
her disease. Octreotide (a long-acting somatostatin analogue) 100 μg s.c. q 12 h was given, 
metronidazole 500 mg i.v. q 8 h, and a nasogastric tube was placed in the stomach and her ascites was 
drained by paracentesis for comfort measures. A week later she improved clinically and a repeated CT 
scan of the pelvis and abdomen showed complete resolution of pneumatosis (fig. 2). 
Discussion 
Many theories have been suggested in the understanding of the pathogenesis of PI. It is 
considered that PI sometimes occurs in patients with malignancies during a period of 
leukocytopenia and may be caused by intestinal mucosal damage due to myelosuppressive 
agents and immunosuppression from prednisolone [5]. Clinical and imaging findings are 
important in the differentiation of this transient pneumatosis from fulminant 
life-threatening causes in this subset of patients. PI, when found incidentally and without 
signs of peritonitis, is a benign and self-limited condition [6]. The literature contains a 
number of reports of PI, however few series which described conservative management 
and outcome. We found 110 patients treated conservatively by different modalities; in 
98 patients (89%) PI resolved while 11 patients (11%) died. Table 1 summarizes 
conservative treatment in PI [5, 7–16]. 
The largest series of conservative management was reported by Morris et al. [16]. 52 
patients were treated by nonoperative management consisting of nasogastric tube  
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decompression and bowel rest. In 48 patients PI was resolved and 3 patients died; of the 
3 patients who died, 1 developed new-onset diabetic ketoacidosis with acute respiratory 
distress syndrome, and the other 2 had complications of graft-versus-host disease 
following bone marrow transplant. Knechtle et al. [7] in 1990 examined the management 
and outcomes of 27 patients who presented with a variety of clinical manifestations and 
etiologies of their PI. They concluded that patients with clinical evidence of bowel 
obstruction or ischemia required surgery, the presence of metabolic acidosis, particularly 
lactic acidosis, and markedly elevated serum amylase suggesting the presence of ischemic 
bowel. Patients whose preoperative diagnosis suggested ischemia as the primary cause of 
PI were more likely to have bowel necrosis than those whose PI resulted from bowel 
obstruction, while those without sepsis or symptoms could be managed conservatively. 16 
of 27 underwent laparotomy, with only one negative exploration. 11 patients were treated 
conservatively, 2 died unrelated to gastrointestinal problems. Of those undergoing 
surgery, 7 out of 9 had necrotic bowel, with a 75% mortality rate in the surgery group 
despite surgical intervention. In the largest series of PI among gynecologic malignancies, 
Horowitz et al. [8] described the management and outcomes of gynecologic oncology 
patients with PI. 15 patients with PI were included; 9 patients were managed surgically 
while 6 were managed conservatively. Pain and tenderness at presentation prompted 
surgical intervention. No other sign or symptom was significant. Of the 6 patients 
managed conservatively, 3 (50%) died within 1 week of diagnosis. Survival for the others 
was 2, 4, and 6 months. Of the 9 patients managed surgically, 6 (67%) died, 4 within 
2 weeks of surgery and the remainder at 2 and 12 months postoperatively. The 3 patients 
who survived all had surgical intervention and none had radiographic or pathologic 
evidence of cancer at the time of presentation. Overall mortality at 6 months was 73% 
(11/15). Surgical management was associated with prolonged intensive care unit stay, 
mechanical ventilation, and sepsis. Conservative management consists of bowel 
decompression by nasogastric tube, parenteral nutrition and antibiotics prophylaxis by 
several investigators [5, 7, 8]. The use of antibiotics in resolving PI was based on the 
bacterial theory, which suggests that gas produced by Escherichia coli, Clostridia, and 
other gas-fermenting organisms is absorbed and retained within the submucosa and the 
lymphatic. The resolution of pneumatosis with the use of metronidazole for the treatment 
of bacterial overgrowth supports this theory [17]. Resolution of pneumatosis by high flow 
oxygen therapy also provides further circumstantial evidence for a bacterial etiology [18]. 
Tchabo et al. [9] reported a case of metastatic uterine leiomyosarcoma undergoing 
resection of the pelvic recurrence; her postoperative course was notable for small bowel 
obstruction and the finding of PI on radiologic studies. The patient developed mild 
abdominal pain, but no tenderness or fever. She was managed with bowel rest, nasogastric 
tube decompression, total parenteral nutrition, and broad-spectrum antibiotics. The 
finding of PI resolved over the ensuing 6 days. Ade-Ajayi et al. [10] also described 
conservative management including 7 days of intravenous antibiotics and 10 days of 
intestinal rest supported by parenteral nutrition in 6 children who developed intestinal 
pneumatosis following bone marrow transplantation; all patients recovered from the 
acute episode. Octreotide has been shown to improve pseudoobstruction which is 
sometimes etiologic. Several authors described good response and resolution of 
pseudoobstruction with the use of octreotide [12, 19–21]. Kobayashi et al. [12] reported a 
26-year-old woman with PI who responded poorly to conventional treatment. 
Subcutaneous administration of octreotide, at a dose of 50 μg/day for 3 weeks, relieved 
symptoms such as nausea and bloating. There was also a marked decrease of intestinal gas 
accumulation, as documented on X-ray films. Several cases of successful conservative 
treatment of PI using hyperbaric oxygen have been reported [18, 22–25]. Grieve and 
Unsworth [14] reported the largest series of hyperbaric oxygen treatment of PI. 2 patients  
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died from unrelated causes; the other 6 were reviewed, and of these 1 declined further 
endoscopy and the other 5 consented. The 11 courses of treatment all resulted in 
pronounced symptomatic responses. This was followed by 7 early symptomatic 
recurrences and 4 long-term cures. These 4 remain asymptomatic and cyst-free at a 
minimum of 4 years to a maximum of 9 years follow-up. Hashimoto et al. [5] described 
4 cases accompanied by hematological malignancies during chemotherapy treatment. All 
suffered from abdominal discomfort. Abdominal X-ray films revealed gas cysts in the 
intestine. All 4 cases were treated conservatively by decompression and hyperbaric 
oxygen. 3 patients improved and 1 patient died of sepsis. Togawa et al. [15] also described 
a favorable outcome with the use of hyperbaric oxygen treatment in 2 cases of IP. 
Conclusion 
The clinical presentation of patients with PI can vary from asymptomatic to critically 
ill. As a result, the significance of PI is closely linked to the clinical context in which it is 
found. It is not difficult to make a precise diagnosis of PI and to prevent unnecessary 
surgical intervention, especially when PI present without clinical evidence of peritonitis. 
Awareness of these rare causes of PI and close observation of selected patients without 
peritonitis may prevent unnecessary invasive surgical explorations. However, observation 
is not appropriate for patients who are hemodynamically unstable or whose clinical 
evaluation suggests a ruptured gastointestinal tract. 
 
 
 
Table 1. Summary of conservative treatment in PI 
Outcome  Author Treatment 
 
Patients 
 death  PI  resolved 
Knechtle et al. [7]  011  NG + antibiotics  02 died (no GI cause)  09 
Horowitz et al. [8]  006  NG + antibiotics  03 died  03 
Hashimoto et al. [5]  004  NG + hyperbaric oxygen  01 died of sepsis  03 
Tchabo et al. [9]  001  NG + antibiotics + TBN
  0–  01 
Ade-Ajayi et al. [10]  006  NG + antibiotics + TBN  0–  06 
Ripamonti et al. [11]  017  NG + antibiotics + Oct
  0– 17 
Kobayashi et al. [12]  001 Oct  0–  01 
Masterson et al. [13]  002 hyperbaric  oxygen  0–  02 
Grieve et al. [14]  008 hyperparic  oxygen  02 died of other cause  06 
Togawa et al. [15]  002 hyperbaric  oxygen  0–  02 
Morris et al. [16]  052 NG  03 48 
Total 110    11  98 
NG = Nasogastric tube decompression and bowel rest; TBN = total parenteral nutrition; Oct = 
octerotide (a long-acting somatostatin analogue); GI = gastrointestinal. 
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Fig. 1. Massive loculated ascites, extensive gastric pneumatosis and portal venous gas, as well as a small 
amount of free gas around the stomach. 
 
 
 
Fig. 2. Marked improvement in portal venous gas and gastric pneumatosis. 
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